Technology ID
TAB-3289

Polyclonal and Monoclonal Antibodies to Human Eosinophil Major Basic Protein, Eosinophil Peroxidase, Eosinophil Cationic Protein, and Eosinophil-Derived Neurotoxin

E-Numbers
E-286-2014-0
Lead Inventor
Nutman, Thomas (NIAID)
Co-Inventors
Davey, Richard (NIAID)
Applications
Research Materials
Lead IC
NIAID
ICs
NIAID
Reagents particularly useful in configuring multiplex assays for simultaneous measurement and quantification of multiple eosinophil granule proteins and for immunohistochemistry. Ultimately these reagents may be used as diagnostics for many eosinophil-mediated disorders.
Commercial Applications
  • A research material that can be used in the development of assays, validation of products or in quality control.
Competitive Advantages
  • Speed up product development with NIH developed material that has already been tested and validated.

Request More Info

Licensing Contact:
Mattes, Theodoric
theodoric.mattes@nih.gov

Publications

  • This record was updated as part of a batch update by the OTT team. The Owner of this record was updated from ‘Admin’ to the Licensing Contact listed on the record on 7/25/2024. If you have any questions or concerns, please reach out to ETT Support.

Collaborations

  • Licensing
Date Published